Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities.

Andreozzi M, Quagliata L, Gsponer JR, Ruiz C, Vuaroqueaux V, Eppenberger-Castori S, Tornillo L, Terracciano LM.

Angiogenesis. 2014 Jul;17(3):519-27. doi: 10.1007/s10456-013-9396-z. Epub 2013 Oct 11.

PMID:
24114200
2.

Cyclin E overexpression and amplification in human tumours.

Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, Seelig S, Kononen J, Mihatsch MJ, Dirnhofer S, Sauter G.

J Pathol. 2003 Jul;200(3):375-82.

PMID:
12845634
3.

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.

Yang J, Yang D, Sun Y, Sun B, Wang G, Trent JC, Araujo DM, Chen K, Zhang W.

Cancer. 2011 Nov 1;117(21):4925-38. doi: 10.1002/cncr.26116. Epub 2011 Apr 14.

4.

AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.

Giltnane JM, Murren JR, Rimm DL, King BL.

Histopathology. 2006 Aug;49(2):161-9.

PMID:
16879393
5.

Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.

Li Y, Fu L, Li JB, Qin Y, Zeng TT, Zhou J, Zeng ZL, Chen J, Cao TT, Ban X, Qian C, Cai Z, Xie D, Huang P, Guan XY.

Gastroenterology. 2014 Jun;146(7):1701-13.e9. doi: 10.1053/j.gastro.2014.02.029. Epub 2014 Feb 21.

PMID:
24561231
6.

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.

Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, Donovan DJ, Thung SN, Solé M, Tovar V, Alsinet C, Ramos AH, Barretina J, Roayaie S, Schwartz M, Waxman S, Bruix J, Mazzaferro V, Ligon AH, Najfeld V, Friedman SL, Sellers WR, Meyerson M, Llovet JM.

Cancer Res. 2008 Aug 15;68(16):6779-88. doi: 10.1158/0008-5472.CAN-08-0742.

7.

Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.

Bieche I, Vacher S, Vallerand D, Richon S, Hatem R, De Plater L, Dahmani A, Némati F, Angevin E, Marangoni E, Roman-Roman S, Decaudin D, Dangles-Marie V.

BMC Cancer. 2014 Mar 13;14:178. doi: 10.1186/1471-2407-14-178.

8.

Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.

Rossi E, Villanacci V, Danesino C, Donato F, Nascimbeni R, Bassotti G.

Rev Esp Enferm Dig. 2011 Dec;103(12):632-9. English, Spanish.

PMID:
22217347
9.

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.

Liang Z, Zeng X, Gao J, Wu S, Wang P, Shi X, Zhang J, Liu T.

BMC Cancer. 2008 Dec 6;8:363. doi: 10.1186/1471-2407-8-363.

10.

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

Latif Z, Watters AD, Dunn I, Grigor K, Underwood MA, Bartlett JM.

Eur J Cancer. 2004 Jan;40(1):56-63.

PMID:
14687790
11.

Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.

Pignot G, Bieche I, Vacher S, Güet C, Vieillefond A, Debré B, Lidereau R, Amsellem-Ouazana D.

Eur Urol. 2009 Oct;56(4):678-88. doi: 10.1016/j.eururo.2008.05.027. Epub 2008 May 23.

PMID:
18513850
12.

Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.

König AM, Reeh M, Dancau AM, Rathjens M, Gros S, Uzunoglu FG, Bockhorn M, Simon R, Sauter G, Marx A, Izbicki JR.

Anticancer Res. 2013 Nov;33(11):4975-82.

PMID:
24222138
13.

Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.

Yang J, Zhao L, Tian W, Liao Z, Zheng H, Wang G, Chen K.

BMC Med Genomics. 2013 Dec 15;6:56. doi: 10.1186/1755-8794-6-56.

14.

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

Clauditz TS, Reiff M, Gravert L, Gnoss A, Tsourlakis MC, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W.

Pathology. 2011 Aug;43(5):459-64. doi: 10.1097/PAT.0b013e3283484a60.

PMID:
21670724
15.

Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.

Fleischmann A, Rotzer D, Seiler R, Studer UE, Thalmann GN.

Eur Urol. 2011 Aug;60(2):350-7. doi: 10.1016/j.eururo.2011.05.035. Epub 2011 May 25.

PMID:
21640482
16.
17.

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, Fleuren GJ, Jordanova ES.

BMC Genomics. 2007 Feb 20;8:53.

18.

Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.

Gunn S, Yeh IT, Lytvak I, Tirtorahardjo B, Dzidic N, Zadeh S, Kim J, McCaskill C, Lim L, Gorre M, Mohammed M.

BMC Cancer. 2010 Jul 28;10:396. doi: 10.1186/1471-2407-10-396.

19.

Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.

Coene ED, Schelfhout V, Winkler RA, Schelfhout AM, Van Roy N, Grooteclaes M, Speleman F, De Potter CR.

Virchows Arch. 1997 May;430(5):365-72.

PMID:
9174626
20.

Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes.

Burmeister K, Quagliata L, Andreozzi M, Eppenberger-Castori S, Matter MS, Perrina V, Grobholz R, Jochum W, Horber D, Moosmann P, Lehmann F, Köberle D, Ng CK, Piscuoglio S, Tornillo L, Terracciano LM.

PLoS One. 2017 Apr 12;12(4):e0175563. doi: 10.1371/journal.pone.0175563. eCollection 2017.

Supplemental Content

Support Center